| Bioactivity | PI3Kα-IN-24 (WR23) is a PI3Kα inhibitor with an IC50 of 0.025 μM and exhibits a significant pAktSer473 suppression effect. PI3Kα-IN-24 can be utilized in cancer research[1]. |
| CAS | 1350960-66-5 |
| Formula | C19H18BrN3O3S |
| Molar Mass | 448.33 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Wu P, et al. Discovery of novel 2-piperidinol-3-(arylsulfonyl)quinoxalines as phosphoinositide 3-kinase α (PI3Kα) inhibitors. Bioorg Med Chem. 2012 May 1;20(9):2837-44. |
PI3Kα-IN-24
CAS: 1350960-66-5 F: C19H18BrN3O3S W: 448.33
PI3Kα-IN-24 (WR23) is a PI3Kα inhibitor with an IC50 of 0.025 μM and exhibits a significant pAktSer473 suppression ef
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.